Age, mean (range) | 36 (3–89) years |
Age groups (years) | |
3–5 | 3% (26/833) |
6–12 | 11% (93/833) |
13–17 | 11% (88/833) |
18–25 | 11% (89/833) |
26–35 | 17% (139/833) |
36–45 | 15% (121/833) |
46–55 | 14% (121/833) |
56–65 | 9% (73/833) |
66+ | 11% (88/833) |
Sex, males | 49% (409/833) |
Malaria parasitaemiaa | 4% (34/833) |
EBV DNA levels in saliva (copies/uL)-median (IQR) | 3364 (557, 18,860) |
KSHV DNA levels in saliva (copies/uL)-median (IQR) | 401 (28, 3921) |
EBV DNA levels in PBMCs (copies/106 cells)-median (IQR) | 1566 (782, 4378) |
KSHV DNA levels in PBMCs (copies/106 cells)-median (IQR) | 203 (4, 620) |
% With detectable EBV in oral fluids | 74% (607/824) |
% With detectable KSHV in oral fluids | 24% (209/874) |
% With detectable EBV in PBMCs | 46% (377/823) |
% With detectable KSHV in PBMCs | 11% (94/869) |